- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prospects for combined use of oncolytic viruses and CAR T-cells ; volume:5 ; number:1 ; day:21 ; month:11 ; year:2017 ; pages:1-27 ; date:12.2017
Journal for ImmunoTherapy of Cancer ; 5, Heft 1 (21.11.2017), 1-27, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Ajina, Adam
- Contributor
-
Maher, John
SpringerLink (Online service)
- DOI
-
10.1186/s40425-017-0294-6
- URN
-
urn:nbn:de:1111-201801059021
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ajina, Adam
- Maher, John
- SpringerLink (Online service)
Other Objects (12)
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Engineering targeted and cytokine-armed oncolytic measles viruses
Oncolytic virus immunotherapy: future prospects for oncology
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Pharmacological control of CAR T-cells by dasatinib
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Engineering targeted and cytokine-armed oncolytic measles viruses
Oncolytic virus immunotherapy: future prospects for oncology
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond
Pharmacological control of CAR T-cells by dasatinib
Oncolytic viruses for cancer immunotherapy
Perspectives on immunotherapy via oncolytic viruses
Oncolytic viruses as therapeutic cancer vaccines
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses
Engineering targeted and cytokine-armed oncolytic measles viruses
Oncolytic virus immunotherapy: future prospects for oncology
Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Oncolytic viruses for triple negative breast cancer and beyond